ClinicalTrials.Veeva
Menu

Find clinical trials for Adenocarcinoma in Cleveland, OH

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Pancreatic Cancer
Colorectal Cancer
Stomach Cancer
Esophageal Cancer
Cancer
Prostatic Cancer

Adenocarcinoma trials near Cleveland, OH, USA:

Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.

The objective of this study is to assess safety and efficacy of BA3182 in Advanced Adenocarcinoma...

Enrolling
Advanced Adenocarcinoma
Drug: BA3182

Phase 1

BioAtla

Cleveland, Ohio, United States and 8 other locations

Recently updated

The purpose of this study is to compare overall survival of quemliclustat, nab-paclitaxel and gemcitabine versus placebo, nab-paclitaxel and gemcitab...

Active, not recruiting
Metastatic Pancreatic Ductal Adenocarcinoma
Drug: Gemcitabine
Drug: Nab-paclitaxel

Phase 3

Arcus Biosciences
Arcus Biosciences

Cleveland, Ohio, United States and 124 other locations

with chemotherapy in participants with previously untreated advanced or metastatic gastric, gastroesophageal junction, or esophageal adenocarcinoma...

Begins enrollment in 1 month
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
Drug: Nivolumab
Drug: Pumitamig

Phase 2, Phase 3

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Cleveland, Ohio, United States and 157 other locations

Locations recently updated

first-line treatment of participants with locally advanced unresectable or metastatic gastric, gastroesophageal junction (GEJ), and esophageal adenocarcinoma...

Active, not recruiting
Advanced Upper Gastrointestinal Tract Adenocarcinoma
Drug: Domvanalimab
Drug: Zimberelimab

Phase 3

Arcus Biosciences
Arcus Biosciences

Cleveland, Ohio, United States and 207 other locations

This study is open to adults with advanced pancreatic cancer. The study tests a type of immunotherapy. It is a protein treatment combined with a viru...

Enrolling
Pancreatic Ductal Adenocarcinoma
Drug: ATP150
Drug: ATP152

Phase 1

Boehringer Ingelheim
Boehringer Ingelheim

Cleveland, Ohio, United States and 20 other locations

This is an open label Phase 2 study to evaluate the efficacy and safety of ACR-368 as monotherapy or with ultra-low dose gemcitabine (ULDG) sensitiza...

Enrolling
Endometrial Adenocarcinoma
Drug: ACR-368
Drug: Gemcitabine

Phase 2

Acrivon Therapeutics

Cleveland, Ohio, United States and 89 other locations

This trial studies tucatinib to find out if it is safe when given with trastuzumab and other anti-cancer drugs (pembrolizumab, FOLFOX, and CAPOX). It...

Active, not recruiting
Esophageal Adenocarcinoma
Gastric Adenocarcinoma
Drug: oxaliplatin
Drug: trastuzumab

Phase 2

Seagen, a wholly owned subsidiary of Pfizer

Cleveland, Ohio, United States and 26 other locations

A multicenter, single-arm, first-in-human study to investigate the safety, pharmacokinetics, and preliminary antitumor activity of PLX-61639 in parti...

Enrolling
Gastroesophageal Junction (GEJ) Adenocarcinoma
Esophageal Adenocarcinoma
Drug: PLX-61639

Phase 1

Plexium, Inc.

Cleveland, Ohio, United States and 9 other locations

The purpose of this study is to determine the recommended Phase 2 dose(s) (RP2D\[s\]) of JNJ-69086420 in Part 1 (Dose Escalation), to determine safet...

Active, not recruiting
Adenocarcinoma
Prostatic Neoplasms
Drug: JNJ-69086420
Radiation: Stereotactic body radiation therapy

Phase 1

Janssen (J&J Innovative Medicine)
Janssen (J&J Innovative Medicine)

Cleveland, Ohio, United States and 10 other locations

Study to compare the safety and efficacy of oregovomab versus placebo, administered in combination with specific cycles of a standard six-cycle chemo...

Active, not recruiting
Fallopian Tube Adenocarcinoma
Fallopian Tube Serous Adenocarcinoma
Drug: Paclitaxel
Biological: Placebo

Phase 3

CanariaBio

Cleveland, Ohio, United States and 148 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems